Alexandria Venture Investment

Alexandria Venture Investment

Alexandria Venture Investment

Xconomy

Cydan, NEA’s Orphan Drug Experiment, Pays Off in $200M Vtesse Deal

Health
$20,000,000 Venture capital (Series C)
Xconomy , FinSMEs

Avelas Bio Raises $20M to Push Cancer-Illuminating Biologic Agent

Funding Health Science
$17,000,000 Venture capital (Series A)
FierceBiotech , vcaonline

Pfizer, NEA-backed rare disease startup bumps up Series A to $42M

Health Funding Science
Xconomy

Syros Cuts Price But Bags $50M in IPO to Fuel Cancer Drug Trials

Stock markets Health Science
$1,000,000 Debt financing
FinSMEs

Precision Microbiome Engineering Company EpiBiome Secures $1M in Debt Financing

Funding
Xconomy

Syros Files For IPO to Push “Gene Control” Drugs Through First Trials

Science Health Funding
$7,500,000 Venture capital (Series B)
Technical.ly Baltimore

Johnson & Johnson joins WellDoc's big funding round

$6,000,000 Venture capital (Series A)
FinSMEs

EpiBiome Completes $6M Series A Financing

Health Funding
$40,000,000 Venture capital (Series C)
PE Hub , FinSMEs

Syros Pharma raises $40 mln

$22,000,000 Venture capital (Series B)
GlobeNewswire News Room

WellDoc® Raises $22 Million in Series B Funding From Samsung Ventures, Merck Global Health Innovation Fund and Other Lea...

$26,800,000 Venture capital (Series C)
FinSMEs , sec

Biological Dynamics Completes $26.8M Series C Financing Round